Analyze Diet
Scientific reports2025; 15(1); 38708; doi: 10.1038/s41598-025-22472-7

Temporal and intra-horse consistency of circulating myostatin concentrations in Thoroughbred racehorses.

Abstract: In Thoroughbred horses, a highly prevalent short interspersed nuclear element (SINE) mutation in the myostatin gene (MSTN) promoter influences circulating myostatin concentration and is associated with muscle morphology, fracture risk and optimal race distance. Our prior data reveal that within horses there is substantial variation in serum myostatin concentration, particularly in MSTN heterozygotes and wild type horses but it was unclear whether such variation relates to within-horse differences or to environmental or temporal effects. Here we report the intra-horse consistency of circulating myostatin, and investigated the hypothesis that it is affected by season. 49 racing Thoroughbreds under identical management were genotyped for the MSTN promoter SINE insertion and myostatin concentrations were measured in plasma with a validated enzyme-linked immunosorbent assay, from blood samples collected repeatedly over a year. As expected, genotype was significantly associated with circulating myostatin, with homozygotes having the lowest concentration, followed by heterozygous and then wild-type horses. Intra-horse plasma myostatin had low to moderate variability throughout the year, within genotyped groups (coefficient of variation: 17 to 23%): aside from a direct mutation effect, horses tended to be low, moderate, or higher myostatin expressers. Neither season, sex, nor age significantly influenced plasma myostatin concentration. Further work is necessary to determine whether an individual's plasma myostatin concentration is associated with any performance advantages, muscle characteristics or fracture risk within SINE genotyped groups.
Publication Date: 2025-11-05 PubMed ID: 41193553PubMed Central: PMC12589566DOI: 10.1038/s41598-025-22472-7Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the consistency of circulating myostatin protein levels within individual Thoroughbred racehorses over time and examined whether factors like season, sex, or age influence these levels.
  • The researchers also explored how genetic differences in the myostatin gene promoter affect circulating myostatin concentrations.

Background

  • Myostatin is a protein that regulates muscle growth, with variations in its levels linked to muscle characteristics and injury risks in horses.
  • A specific genetic mutation—a short interspersed nuclear element (SINE) insertion in the promoter region of the myostatin gene (MSTN)—is common in Thoroughbred racehorses and known to affect circulating myostatin concentrations.
  • This SINE mutation correlates with traits relevant to racing such as muscle morphology, fracture risk, and optimal race distance.
  • Previous observations showed considerable variation in serum myostatin levels within horses, especially among those with heterozygous or wild-type MSTN genotypes, but it was unclear whether this variability was due to individual differences or external factors like environment or time.

Objectives

  • To determine the consistency of circulating myostatin levels within individual horses over a one-year period.
  • To analyze whether circulating myostatin concentrations are influenced by season, sex, or age.
  • To confirm if MSTN genotypes predict plasma myostatin concentrations in a group of standardized management Thoroughbred racehorses.

Methods

  • Sample Population: 49 Thoroughbred racehorses managed identically were included.
  • Genotyping: Horses were genotyped for the MSTN promoter SINE insertion mutation, categorizing them into homozygous mutant, heterozygous, or wild-type groups.
  • Data Collection: Blood samples were collected repeatedly over a year to measure plasma myostatin concentrations.
  • Myostatin Measurement: A validated enzyme-linked immunosorbent assay (ELISA) was used to quantify circulating myostatin levels.
  • Analysis: Within-horse variability in myostatin concentration over time was computed using the coefficient of variation (CV). The effects of genotype, season, sex, and age on myostatin levels were statistically evaluated.

Key Findings

  • Genotype Effects:
    • Horses homozygous for the SINE mutation had the lowest plasma myostatin concentrations.
    • Heterozygous horses showed intermediate levels.
    • Wild-type horses (no mutation) exhibited the highest myostatin concentrations.
  • Intra-Horse Variability:
    • Within individual horses, myostatin levels showed low to moderate variability over the year (CV ranged from 17% to 23%) within genotype groups.
    • This suggests a relatively consistent baseline myostatin expression per horse, with some horses naturally expressing lower or higher levels.
  • Influence of External Factors:
    • Season did not significantly affect circulating myostatin levels.
    • Sex and age were also not significant modulators of plasma myostatin concentrations.

Implications

  • The findings reinforce that the MSTN promoter mutation is a major genetic control element of circulating myostatin levels in Thoroughbreds.
  • The individual consistency in myostatin expression implies stable regulation within horses regardless of seasonal or demographic factors.
  • These consistent individual myostatin levels might influence muscle characteristics and injury risks but require further investigation.
  • Understanding myostatin profiles more thoroughly could potentially assist in tailoring training or management plans according to genetic and physiological muscle growth predispositions.

Recommended Future Research

  • Explore whether an individual horse’s stable myostatin concentration correlates with performance outcomes such as race success or muscle condition.
  • Investigate relationships between circulating myostatin and fracture risk within genotypic groups to assess potential predictive or preventative strategies.
  • Expand sample size and include different management settings to validate the current findings more broadly.

Cite This Article

APA
Hanousek K, O'Hara V, Riddell DO, Piercy RJ. (2025). Temporal and intra-horse consistency of circulating myostatin concentrations in Thoroughbred racehorses. Sci Rep, 15(1), 38708. https://doi.org/10.1038/s41598-025-22472-7

Publication

ISSN: 2045-2322
NlmUniqueID: 101563288
Country: England
Language: English
Volume: 15
Issue: 1
Pages: 38708
PII: 38708

Researcher Affiliations

Hanousek, Katherine
  • Comparative Neuromuscular Diseases Laboratory, Royal Veterinary College, London, UK.
O'Hara, Victoria
  • Comparative Neuromuscular Diseases Laboratory, Royal Veterinary College, London, UK.
Riddell, Dominique O
  • Comparative Neuromuscular Diseases Laboratory, Royal Veterinary College, London, UK.
Piercy, Richard J
  • Comparative Neuromuscular Diseases Laboratory, Royal Veterinary College, London, UK. rpiercy@rvc.ac.uk.

MeSH Terms

  • Animals
  • Myostatin / blood
  • Myostatin / genetics
  • Horses / genetics
  • Horses / blood
  • Female
  • Male
  • Genotype
  • Short Interspersed Nucleotide Elements
  • Promoter Regions, Genetic
  • Seasons

Grant Funding

  • 6044 / Horserace Betting Levy Board

Conflict of Interest Statement

Declarations. Competing interests: The authors declare no competing interests.

References

This article includes 32 references
  1. McPherron AC, Lawler AM, Lee S-J. Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member.. 83–90 (1997).
    doi: 10.1038/387083a0pubmed: 9139826google scholar: lookup
  2. Beyer TA, Narimatsu M, Weiss A, David L, Wrana JL. The TGFβ superfamily in stem cell biology and early mammalian embryonic development.. 2268–2279 (2013).
    doi: 10.1016/j.bbagen.2012.08.025pubmed: 22967760google scholar: lookup
  3. Whittemore L-A et al. Inhibition of myostatin in adult mice increases skeletal muscle mass and strength.. 965–971 (2003).
    doi: 10.1016/S0006-291X(02)02953-4pubmed: 12559968google scholar: lookup
  4. Zimmers TA et al. Induction of cachexia in mice by systemically administered myostatin.. (296), 1486–1488 (2002).
    doi: 10.1126/science.1069525pubmed: 12029139google scholar: lookup
  5. Grobet L et al. A deletion in the bovine myostatin gene causes the double–muscled phenotype in cattle.. 71–74 (1997).
    doi: 10.1038/ng0997-71pubmed: 9288100google scholar: lookup
  6. Mosher DS et al. A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs.. e79 (2007).
  7. Stinckens A et al. Characterization of the complete porcine MSTN gene and expression levels in pig breeds differing in muscularity.. 586–596 (2008).
  8. Kijas JW et al. Evidence for multiple alleles effecting muscling and fatness at the Ovine GDF8 locus.. 80 (2007).
    doi: 10.1186/1471-2156-8-80pmc: PMC2212645pubmed: 17996073google scholar: lookup
  9. Girgenrath S, Song K, Whittemore L-A. Loss of myostatin expression alters fiber-type distribution and expression of myosin heavy chain isoforms in slow- and fast-type skeletal muscle.. 34–40 (2005).
    doi: 10.1002/mus.20175pubmed: 15468312google scholar: lookup
  10. Ploquin C et al. Lack of myostatin alters intermyofibrillar mitochondria activity, unbalances redox status, and impairs tolerance to chronic repetitive contractions in muscle.. E1000–E1008 (2012).
    doi: 10.1152/ajpendo.00652.2011pubmed: 22318951google scholar: lookup
  11. Amthor H et al. Lack of myostatin results in excessive muscle growth but impaired force generation.. 1835–1840 (2007).
    doi: 10.1073/pnas.0604893104pmc: PMC1794294pubmed: 17267614google scholar: lookup
  12. Wu LF et al. Relative abundance of mature myostatin rather than total myostatin is negatively associated with bone mineral density in Chinese.. 1329–1336 (2018).
    doi: 10.1111/jcmm.13438pmc: PMC5783859pubmed: 29247983google scholar: lookup
  13. Bialek P et al. A myostatin and activin decoy receptor enhances bone formation in mice.. 162–171 (2014).
    doi: 10.1016/j.bone.2013.12.002pubmed: 24333131google scholar: lookup
  14. Kellum E et al. Myostatin (GDF-8) deficiency increases fracture callus size, Sox-5 expression, and callus bone volume.. 17–23 (2009).
    doi: 10.1016/j.bone.2008.08.126pmc: PMC2648293pubmed: 18852073google scholar: lookup
  15. Binns MM, Boehler DA, Lambert DH. Identification of the myostatin locus (MSTN) as having a major effect on optimum racing distance in the Thoroughbred horse in the USA.. 154–158 (2010).
  16. Hill EW. The contribution of myostatin (MSTN) and additional modifying genetic loci to race distance aptitude in Thoroughbred horses racing in different geographic regions.. 625–633 (2019).
    doi: 10.1111/evj.13058pubmed: 30604488google scholar: lookup
  17. Tozaki T. Sequence variants at the myostatin gene locus influence the body composition of thoroughbred horses.. 1617–1624 (2011).
    doi: 10.1292/jvms.11-0295pubmed: 21836385google scholar: lookup
  18. Petersen JL. Genome-wide analysis reveals selection for important traits in domestic horse breeds.. e1003211 (2013).
  19. Petersen JL, Valberg SJ, Mickelson JR, McCue ME. Haplotype diversity in the equine myostatin gene with focus on variants associated with race distance propensity and muscle fiber type proportions.. 827–835 (2014).
    doi: 10.1111/age.12205pmc: PMC4211974pubmed: 25160752google scholar: lookup
  20. Dall’Olio S, Scotti E, Fontanesi L, Tassinari M. Analisi dell’inserzione della breve sequenza interspersa (sine) di 227 bp nel promotore del gene miostatina in diverse razze di cavalli.. 193–197 (2014).
    pubmed: 25273961
  21. Hill EW, Ryan DP, MacHugh DE. Horses for Courses: a DNA-based Test for Race Distance Aptitude in Thoroughbred Racehorses.. 203–208 (2012).
    pubmed: 22845060
  22. Rooney MF, Hill EW, Kelly VP, Porter RK. The, “speed gene” effect of myostatin arises in Thoroughbred horses due to a promoter proximal SINE insertion.. e0205664 (2018).
  23. O’Hara V. A highly prevalent SINE mutation in the myostatin (MSTN) gene promoter is associated with low circulating myostatin concentration in Thoroughbred racehorses.. 7916 (2021).
    doi: 10.1038/s41598-021-86783-1pmc: PMC8041750pubmed: 33846367google scholar: lookup
  24. Tozaki T. A candidate- SNP retrospective cohort study for fracture risk in Japanese Thoroughbred racehorses.. 43–50 (2020).
    doi: 10.1111/age.12866pubmed: 31612520google scholar: lookup
  25. Kowalik S, Wiśniewska A, Kędzierski W, Janczarek I. Concentrations of circulating irisin and myostatin in race and endurace Purebred Arabian horses—Preliminary study.. 2268 (2020).
    doi: 10.3390/ani10122268pmc: PMC7760310pubmed: 33271939google scholar: lookup
  26. Morrison PK. Preliminary investigation into a potential role for myostatin and its receptor (ActRIIB) in lean and obese horses and ponies.. e112621 (2014).
  27. Swanson DL, Sabirzhanov B, VandeZande A, Clark TG. Seasonal variation of myostatin gene expression in pectoralis muscle of house sparrows ( ) is consistent with a role in regulating thermogenic capacity and cold tolerance.. 121–128 (2009).
    doi: 10.1086/591099pubmed: 19199561google scholar: lookup
  28. Braulke LJ, Heldmaier G, Berriel Diaz M, Rozman J, Exner C. Seasonal changes of myostatin expression and its relation to body Mass acclimation in the Djungarian hamster, .. 548–556 (2010).
    doi: 10.1002/jez.626pubmed: 20623496google scholar: lookup
  29. Szulc P. Endocrine and clinical correlates of myostatin serum concentration in men—The Strambo study.. 3700–3708 (2012).
    doi: 10.1210/jc.2012-1273pubmed: 22802085google scholar: lookup
  30. Murphy BA. Circadian and circannual regulation in the horse: Internal timing in an elite athlete.. 14–24 (2019).
    doi: 10.1016/j.jevs.2019.02.026pubmed: 31084748google scholar: lookup
  31. Grade CVC, Mantovani CS, Alvares LE. Myostatin gene promoter: structure, conservation and importance as a target for muscle modulation.. 32 (2019).
    doi: 10.1186/s40104-019-0338-5pmc: PMC6477727pubmed: 31044074google scholar: lookup
  32. Welle S, Burgess K, Thornton CA, Tawil R. Relation between extent of myostatin depletion and muscle growth in mature mice.. 935–940 (2009).
    doi: 10.1152/ajpendo.00179.2009pmc: PMC2763790pubmed: 19654287google scholar: lookup

Citations

This article has been cited 0 times.